rhBSSL
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Swedish Orphan Biovitrum
Overview
rhBSSL is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
rhBSSL clinical trials
Explore related
Medical disclaimer. This page summarizes research about rhBSSL for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.